Menu Search
Equities

Deversify Health AB (publ)

DEV:STO

Deversify Health AB (publ)

Actions
  • Price (SEK)0.022
  • Today's Change0.001 / 6.80%
  • Shares traded902.73k
  • 1 Year change-81.91%
  • Beta0.5795
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Deversify Health AB (publ) had revenues fall -31.53% from 27.26m to 18.66m, though the company grew net income from a loss of 23.26m to a smaller loss of 21.16m.
Gross margin114.37%
Net profit margin-88.80%
Operating margin-86.96%
Return on assets-124.86%
Return on equity-317.41%
Return on investment-188.09%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Deversify Health AB (publ) fell by 2.52m. Cash Flow from Financing totalled 2.34m or 12.54% of revenues. In addition the company used 4.02m for operations while cash used for investing totalled 847.00k.
Cash flow per share-0.0778
Price/Cash flow per share--
Book value per share-0.0648
Tangible book value per share-0.0648
More ▼

Balance sheet in SEKView more

Deversify Health AB (publ) uses little or no debt in its capital structure.
Current ratio0.1601
Quick ratio0.1601
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in SEK

Year on year, growth in earnings per share excluding extraordinary items increased 21.11%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		12.41
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.